We are live on
!
Find out more
ARS Pharmaceuticals
SPRY
SPRY
202 hedge funds and large institutions have $753M invested in ARS Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 61 increasing their positions, 56 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
294% more call options, than puts
Call options by funds: $2.1M | Put options by funds: $532K
64% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 25
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
7% more funds holding
Funds holding: 189 → 202 (+13)
4.18% more ownership
Funds ownership: 90.01% → 94.19% (+4.2%)
9% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 56
27% less capital invested
Capital invested by funds: $1.04B → $753M (-$283M)
Holders
202
Holders Change
+13
Holders Change %
+6.88%
% of All Funds
2.49%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
41
Increased
61
Reduced
56
Closed
25
Calls
$2.1M
Puts
$532K
Net Calls
+$1.56M
Net Calls Change
+$1.05M
Top Buyers
| 1 |
Millennium Management
New York
|
+$27M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$17.3M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$9.51M |
| 4 |
TCM
Tyro Capital Management
Miami,
Florida
|
+$9.33M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$7.05M |
Top Sellers
| 1 |
CC
Casdin Capital
New York
|
-$18.6M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
-$17.5M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$7.5M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.88M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$4.62M |